NEUP (Neuphoria Therapeutics) FFO


NEUP Neuphoria Therapeutics Inc NEUP
32 GF Score
Price $4.53
! 1 Warning Sign
View Full Analysis

What is Neuphoria Therapeutics FFO?

FFO (Funds from operations) only applies to REITs.

NEUP
32GF Score
Neuphoria Therapeutics Inc NEUP
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Neuphoria Therapeutics Business Description

Address 100 Summit Drive, Burlington, MA, USA, 01803
Neuphoria Therapeutics Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder. The Company operates through a single operating and reportable segment focused on the discovery and development of allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need.
32GF Score

Get the complete analysis for NEUP

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.53
Price